Sertraline-induced hypersensitivity pneumonitis.
Gursharan VirdeeJohn BleasdaleMohammed IkramullahEmma Graham-ClarkePublished in: BMJ case reports (2019)
Hypersensitivity pneumonitis (HP), also known as extrinsic allergic alveolitis, is a granulomatous, non-IgE-mediated hypersensitivity reaction of the alveoli and distal bronchioles presenting as an acute, subacute or chronic condition. It is most commonly associated with exposure to extrinsic allergens (eg, avian dust, mould and tobacco) and medications including antiarrhythmics (eg, amiodarone), cytotoxics (eg, methotrexate) and antiepileptics (eg, carbamazepine). Individuals diagnosed with this condition can present with severe hypoxia and respiratory failure. The fundamental principle of management is to remove the causative allergen. Evidence implicating selective serotonin reuptake inhibitors as a causative agent is limited, and this case report describes a rare clinical presentation of HP associated with sertraline, how it was diagnosed and subsequently treated. It is anticipated that raising awareness of this interaction will assist multidisciplinary teams, managing patients diagnosed with HP, to be more cognisant of sertraline as being an aetiological factor for this condition.
Keyphrases
- drug induced
- respiratory failure
- case report
- end stage renal disease
- newly diagnosed
- extracorporeal membrane oxygenation
- interstitial lung disease
- ejection fraction
- mechanical ventilation
- chronic kidney disease
- peritoneal dialysis
- minimally invasive
- patient reported outcomes
- intensive care unit
- endothelial cells
- health risk
- allergic rhinitis
- rheumatoid arthritis
- quality improvement
- acute respiratory distress syndrome
- health risk assessment
- hepatitis b virus
- heavy metals
- drinking water
- atopic dermatitis